Compounds > guanidine

guanidine and oseltamivir

guanidine has been researched along with oseltamivir in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Mitrasinovic, PM1
Cheng, YS; Fang, JM; Lee, PS; Liu, KC; Wang, SY; Wong, CH1
Govorkova, EA; Ivachtchenko, AV; Ivanenkov, YA; Ivashchenko, AA; Jones, JC; Karapetian, RN; Pascua, PNQ; Penaflor, MK; Shkil, DO1

Reviews

1 review(s) available for guanidine and oseltamivir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for guanidine and oseltamivir

ArticleYear
On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Biophysical chemistry, 2009, Volume: 140, Issue:1-3

    Topics: Animals; Binding Sites; Birds; Computer Simulation; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Guanidine; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Models, Chemical; Molecular Structure; Neuraminidase; Oseltamivir; Protein Conformation; Structure-Activity Relationship; Viral Proteins

2009
Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.
    Bioorganic & medicinal chemistry, 2011, Aug-15, Volume: 19, Issue:16

    Topics: Administration, Oral; Antiviral Agents; Carbon Dioxide; Cell Line; Drug Evaluation, Preclinical; Enzyme Inhibitors; Esters; Guanidine; Humans; Hydrophobic and Hydrophilic Interactions; Influenza A virus; Influenza, Human; Ions; Molecular Structure; Naphthols; Neuraminidase; Oseltamivir; Prodrugs; Zanamivir

2011
Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses.
    Antiviral research, 2023, Volume: 217

    Topics: Antiviral Agents; Drug Resistance, Viral; Enzyme Inhibitors; Guanidine; Guanidines; Herpesvirus 1, Cercopithecine; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza A Virus, H7N9 Subtype; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir

2023